Abbott Laboratories ABT

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$69.44B
Market Cap
$168.58B
Margin of Safety
-142.8%
Intrinsic / Market Ratio
0.41

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

63.90B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

91.67B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

52.75B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

69.44B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

69.44B USD

from the sum above

Market Cap

168.58B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.41×

the ratio the screener ranks by; Margin of Safety -142.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 63.90B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)90.68B USD
−②Net Debt Today26.78B USD
+③Growth Value0 USD
=Value63.90B USD

EPV of the Operations (NOPAT over WACC)

90.68B USD

Net debt today

-26.78B USD

Growth Value

0 USD

Value

63.90B USD

①EPV (earnings power value)

90.68B USD

②Net Debt Today

26.78B USD

③Growth Value

0 USD

Market value

Market Cap168.58B USD

Today's price times the shares.

Value vs market

Margin of Safety-163.8%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 91.67B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE58.87B USD
+②Equity at Year 15, Today32.80B USD
=Value91.67B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

58.87B USD

②Equity at Year 15, Today

32.80B USD

Market value

Market Cap168.58B USD

Today's price times the shares.

Value vs market

Margin of Safety-83.9%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 52.75B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 52.75B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap168.58B USD

Today's price times the shares.

Value vs market

Margin of Safety-219.6%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.86%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.59×Market Risk Premium 6.00%= 8.02%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 1.94B USDPretax Income 8.47B USD= 22.94%

The tax the interest saves.

Interest Expense =EBIT 8.97B USD−Pretax Income 8.47B USD= 493.49M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 493.49M USDTotal Debt 34.08B USD×(1 − Tax Rate for WACC 22.94%)= 1.12%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 34.08B USDMarket Cap + Total Debt 168.58B USD + 34.08B USD= 16.82%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 83.18%×Cost of Equity 8.02%+Debt Weight 16.82%×Cost of Debt 1.12%= 6.86%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 110.54B USD − Total Liabilities 57.79B USD = Book Value Today 52.75B USD

Total Debt 34.08B USD − Cash and Short-Term Investments 7.30B USD = Net Debt Today 26.78B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.4%at most 5%passes1,741,813,154 / 1,734,076,358
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.8%at least -10.0%passes(9.58B USD − 6.53B USD) ÷ 110.54B USD
Price to bookMarket Cap ÷ Book Value Today3.20×at most 3×does not pass168.58B USD ÷ 52.75B USD
Operating marginOperating Income ÷ Revenue18.2%above 10.0%passes8.06B USD ÷ 44.37B USD
Revenue growthRevenue ÷ Revenue a Year Before − 15.7%above 10.0%does not pass44.37B USD / 41.99B USD
Net cash(Cash − Total Debt) ÷ Market Cap-16.2%above -30%passes(6.81B USD − 34.08B USD) ÷ 168.58B USD
Operating efficiencyOperating Income ÷ Gross Profit32.2%above 25.0%passes8.06B USD ÷ 25.03B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

97 USD

Enterprise value

195.27B USD

market cap plus net debt

EV / EBITDA

16.70×

Price / book

3.27×

the provider's book

Price / earnings

31.29×

Return on equity

10.6%

the provider's, not the engine's

Profit margin

11.7%

Revenue growth

13.0%

Analyst target, mean

120 USD

Analysts

25

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

43.70B40.15B41.99B44.37B

Gross profit

24.54B22.16B23.27B25.03B

Operating income

8.37B6.48B6.83B8.06B

EBITDA

operating income before depreciation and amortisation

12.14B10.55B10.80B12.09B

Pretax income

8.31B6.67B7.02B8.47B

Net income

6.94B5.73B13.42B6.53B

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

6.94B5.76B13.39B6.49B

R&D

2.89B2.74B2.85B2.94B
Balance sheet, year end

Total assets

74.51B73.29B81.50B86.80B

Total liabilities

37.57B34.42B33.55B33.98B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

36.72B38.64B47.71B52.18B

Total debt

17.73B15.64B15.04B13.87B

Cash and equivalents

9.89B6.90B7.62B8.53B

Net PP&E

fixed assets after depreciation

9.17B10.16B10.67B11.83B

Working capital

current assets less current liabilities

9.74B8.84B9.51B9.51B
Cash flow

Operating cash flow

9.59B7.27B8.57B9.58B

Capital expenditure

paid out, so below zero

-1.78B-2.20B-2.21B-2.17B

Depreciation and amortisation

3.27B3.25B3.22B3.12B

Free cash flow

operating cash flow plus capital expenditure

7.81B5.06B6.36B7.40B